Blueprint Medicines Corpo...

NASDAQ: BPMC · Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM

Blueprint Medicines Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
508.82M 249.38M 204.04M 180.08M
Cost of Revenue
20.16M 12.8M 17.81M 17.93M
Gross Profit
488.66M 236.58M 186.22M 162.15M
Operating Income
-212.04M -486.28M -549.25M -648.46M
Interest Income
40.66M 32.81M 17.75M 2.39M
Pretax Income
-65.86M -506.02M -552.28M -641.08M
Net Income
-67.09M -506.98M -557.52M -644.09M
Selling & General & Admin
359.27M 295.14M 237.37M 195.29M
Research & Development
341.43M 427.72M 477.42M 601.03M
Other Expenses
n/a n/a 8.95M 7.8M
Operating Expenses
700.71M 722.86M 723.74M 804.13M
Interest Expense
68.81M 51.6M 16.77M n/a
Selling & Marketing Expenses
96.6M 16.9M 18.1M 13.5M
Cost & Expenses
720.87M 735.66M 741.55M 822.06M
Income Tax Expense
1.23M 968K 5.24M 3M
Shares Outstanding (Basic)
62.86M 60.56M 59.64M 58.52M
Shares Outstanding (Diluted)
62.86M 60.56M 59.64M 58.52M
EPS (Basic)
-1.07 -8.37 -9.35 -11.01
EPS (Diluted)
-1.07 -8.37 -9.35 -11.01
EBITDA
19.23M -470.36M -515.41M -628.3M
EBIT
2.94M -482.02M -528.57M -641.08M
Depreciation & Amortization
16.29M 11.66M 20.1M 12.79M